Altre lingue Gemina Laboratories Ltd.

Azioni

GLAB

CA3686501071

Tempo differito Canadian Securities Exchange Altri mercati azionari 21:05:39 03/05/2024			Variaz. 5gg	Var. 1 gen.
0,54 ^CAD	0,00%		+8,00%	0,00%

02/04	I Laboratori Gemina firmano il primo accordo di licenza strategica	CI
2023	Gemina Laboratories Ltd. I risultati degli utili per il terzo trimestre e i nove mesi conclusi il 31 ottobre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Gemina Laboratories : Financial Statement Request Form	11/04
Gemina Laboratories : Notice of Meeting and Management Information Circular	11/04
Gemina Laboratories Sign First Strategic License Agreement	02/04
Gemina Laboratories Ltd. announced that it has received CAD 0.91 million in funding	18/03
Gemina Laboratories Ltd. announced that it expects to receive CAD 1 million in funding	22/02
Gemina Laboratories Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	29/12
Gemina Laboratories Ltd. Announces the Resignation of Rob Porter as Director and President	29/12
READYGO DIAGNOSTICS INITIATES AN ASSAY DEVELOPMENT CONTRACT WITH GEMINA LABORATORIES FOR THE DETECTION OF DENGUE FROM SALIVA SAMPLES	10/10/23
Gemina Laboratories Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	29/09/23
Gemina Laboratories : to participate in poster session at AACC scientific meeting	15/06/23
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ANNOUNCE THE FEASIBILITY OF MYCOBACTERIUM TUBERCULOSIS (MTB) DIAGNOSIS IN SALIVA	05/06/23
Gemina Laboratories Ltd. Laboratories and ReadyGo Diagnostics Limited Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva	05/06/23
Gemina Laboratories Ltd. Reports Earnings Results for the Full Year Ended January 31, 2023	01/06/23
Gemina Laboratories Ltd. Auditor Raises 'Going Concern' Doubt	31/05/23
Gemina Laboratories Ltd. Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement	17/05/23
READYGO DIAGNOSTICS AND GEMINA LABORATORIES ENTER AN ASSAY DEVELOPMENT AGREEMENT FOR THE RAPID DETECTION OF MYCOBACTERIUM TUBERCULOSIS (MTB)	19/04/23
Gemina Laboratories Ltd. announced that it has received CAD 2.604746 million in funding	27/03/23
Gemina Laboratories Ltd. Announces Board Changes	07/03/23
Gemina Laboratories Ltd. Announces Board Changes	25/01/23
Gemina Laboratories Ltd. Completes Influenza A/B Diagnostic Test Prototype	06/01/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Gemina Laboratories Ltd.

Azioni

GLAB

CA3686501071

Altre lingue

Filtri